Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript
01:40am, Friday, 08'th Aug 2025
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Human Resources & Corporate Commu
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say
06:31pm, Thursday, 07'th Aug 2025
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
06:15pm, Thursday, 07'th Aug 2025
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.94 per share a year ago.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
04:05pm, Thursday, 07'th Aug 2025
- Reports Net Revenues of $174.4 million for the Three Months Ended June 30, 2025 - GAAP net income of $31.0 million, or $0.64 per share, for the second quarter - Adjusted non-GAAP net income of $40.9
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 31'st Jul 2025
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More
09:12am, Tuesday, 29'th Jul 2025
Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual strategy. The business is defensive, with a diversified product mix and pipeli
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
06:00am, Tuesday, 29'th Jul 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / July 29, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2025 ended June 30, 202
What Makes Amphastar (AMPH) a New Buy Stock
01:00pm, Wednesday, 23'rd Jul 2025
Amphastar (AMPH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
10:41am, Wednesday, 23'rd Jul 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks
10:36am, Wednesday, 23'rd Jul 2025
Amphastar (AMPH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
04:05pm, Monday, 14'th Jul 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / July 14, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a bio-pharmaceutical company focused on developing, manufacturing, and marketing complex generic
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
06:00am, Thursday, 22'nd May 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will
Amphastar Pharmaceuticals: Navigating Through An Inflection Year
11:32am, Sunday, 11'th May 2025
Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under eight times forward earnings, but the company is going through an 'inflectio
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
06:00am, Friday, 09'th May 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 9, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be partici
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics
08:30pm, Wednesday, 07'th May 2025
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Stree
